STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

LLY ELI LILLY & COMPANY StockScouter® Report

9

StockScouter® Score

ELI LILLY & COMPANY, a large cap growth company in the healthcare sector, is expected to outperform the market over the next six months with less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The multi-period measure of relative price change and consistency is well above average. Positive
  • The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
  • One or more analysts has significantly increased quarterly earnings estimates for LLY. Positive

 

Concerns

  • The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that large cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 20% done.
Progress: 100% done.
Low
High

Core Model Grades

A
D
D
A

Previous Ratings

7
6
6